United States Court of Federal Claims, 2023

Barenblit v. Secretary of Health and Human Services

United States Court of Federal Claims · Decided November 27, 2023 · Nora Beth Dorsey

Opinion

In the United States Court of Federal Claims

OFFICE OF SPECIAL MASTERS Filed: October 31, 2023

* * * * * * * * * * * * * * * AMBER BARENBLIT, on behalf of A.S., * a minor, *

* Petitioner, * No. 18-180V

* v. * Special Master Dorsey

* SECRETARY OF HEALTH * Decision Based on Stipulation; Diphtheria- AND HUMAN SERVICES, * Tetanus-Acellular Pertussis (“DTaP”)

* Vaccine; Hepatitis B (“Hep B”) Vaccine; Respondent. * Inactivated Polio (“IPV”) Vaccine;

* Haemophilus Influenzae Type B (“Hib”) * Vaccine; Pneumococcal conjugate (“PCV”) * Vaccine; Rotavirus Vaccine; Kawasaki * Disease; Encephalopathy; Seizure Disorder.

* * * * * * * * * * * * * * * Mark Theodore Sadaka, Law Offices of Sadaka Associates, LLC, Englewood, NJ, for Petitioner. Julia Marter Collison, U.S. Department of Justice, Washington, DC, for Respondent.

DECISION BASED ON STIPULATION1

On February 5, 2018, Amber Barenblit, on behalf of her minor daughter A.S. (“Petitioner”), filed a petition in the National Vaccine Injury Program2 alleging that as a result of a diphtheria-tetanus-acellular pertussis (“DTaP”), hepatitis B (“Hep B”), inactivated polio (“IPV”), haemophilus influenzae type b (“Hib”), Pneumococcal conjugate (“PCV”), and Rotavirus vaccines administered on February 11, 2015 and April 30, 2015, A.S. sustained Kawasaki Disease, encephalopathy, and a seizure disorder. Petition at Preamble (ECF No. 1).

On October 31, 2023, the parties filed a stipulation recommending an award of compensation to Petitioner. Stipulation (ECF No. 123). Respondent denies that A.S. sustained any vaccine-related injuries; denies that the vaccines caused A.S.’s alleged injuries, or any other injury; and denies that her current condition is a sequalae of any vaccine-related injury. Nevertheless, the parties agree to the joint stipulation, attached hereto as Appendix A. The undersigned finds the stipulation reasonable and adopts it as the decision of the Court in awarding damages, on the terms set forth therein.

The parties stipulate that Petitioner shall receive the following compensation: A lump sum of $15,000.00, in the form of a check payable to Petitioner as guardian/conservator of A.S.’s estate.

Stipulation at ¶ 8. This amount represents compensation for all damages that would be available under 42 U.S.C. § 300aa-15(a).

The undersigned approves the requested amount for Petitioner’s compensation. Accordingly, an award should be made consistent with the stipulation.

In the absence of a motion for review filed pursuant to RCFC Appendix B, the Clerk of Court SHALL ENTER JUDGMENT in accordance with the terms of the parties’ stipulation.3

IT IS SO ORDERED. s/Nora B. Dorsey Nora B. Dorsey Special Master

1 Because this Decision contains a reasoned explanation for the action in this case, the undersigned is required to post it on the United States Court of Federal Claims’ website and/or at https://www.govinfo.gov/app/collection/uscourts/national/cofc in accordance with the E- Government Act of 2002. 44 U.S.C. § 3501 note (2018) (Federal Management and Promotion of Electronic Government Services). This means the Decision will be available to anyone with access to the Internet. In accordance with Vaccine Rule 18(b), Petitioner has 14 days to identify and move to redact medical or other information, the disclosure of which would constitute an unwarranted invasion of privacy. If, upon review, the undersigned agrees that the identified material fits within this definition, the undersigned will redact such material from public access. 2 The National Vaccine Injury Compensation Program is set forth in Part 2 of the National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755, codified as amended, 42 U.S.C. §§ 300aa-10 to -34 (2018) (“Vaccine Act” or “the Act”). All citations in this Decision to individual sections of the Vaccine Act are to 42 U.S.C.A. § 300aa. 3 Pursuant to Vaccine Rule 11(a), entry of judgment is expedited by the parties’ joint filing of notice renouncing the right to seek review.

Case-law data current through September 30, 2026. Source: CourtListener bulk data.